GT Biopharma, Inc. (GTBP)

Last Closing Price: 2.70 (2025-05-29)

Earnings Announcements: Estimated vs Actual

On 2025-05-15, GT Biopharma, Inc. (GTBP) announced earnings per share of $-0.76 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.64.

The next expected annoucement date for quarterly earnings is 2025-08-13, with an average estimated earnings per share of $-0.68 for the fiscal quarter ending 2025-06-30.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.

Announcement Date Fiscal Quarter End Estimated EPS Actual EPS
2025-05-15 2025-03-31 $-0.64 $-0.76
2025-02-21 2024-12-31 $-1.55 $-1.66
2024-11-14 2024-09-30 -- $-1.53
2024-08-14 2024-06-30 -- $-2.24
2024-05-15 2024-03-31 $-2.70 $-2.12
2023-11-01 2023-09-30 $-3.00 $-1.80
2023-08-07 2023-06-30 $-3.00 $-2.70
2023-05-15 2023-03-31 $-4.80 $-2.40
2023-03-30 2022-12-31 -- $-5.41
2022-10-31 2022-09-30 $-3.30 $-6.61
2022-08-11 2022-06-30 $-5.41 $-3.00
2022-05-16 2022-03-31 $-6.91 $-5.11
2022-03-28 2021-12-31 $-6.31 $-15.62
2021-11-10 2021-09-30 $-6.31 $-5.11
2021-08-23 2021-06-30 $-8.41 $-4.50
2021-05-17 2021-03-31 $-7.51 $-54.95
2020-11-13 2020-09-30 -- $-20.43
2020-08-14 2020-06-30 -- $-40.86
2020-05-15 2020-03-31 -- $-10.21
2019-11-14 2019-09-30 -- $-219.61
2019-08-14 2019-06-30 -- $-25.54
2019-05-15 2019-03-31 -- $-45.96
2019-03-29 2018-12-31 -- $-35.75
2018-11-15 2018-09-30 -- $-71.50
2018-08-14 2018-06-30 -- $-91.93
2018-05-15 2018-03-31 -- $-102.14
2017-11-14 2017-09-30 -- $-4208.29
2017-08-11 2017-06-30 -- $-914643.75
2017-04-28 2017-03-31 -- $-6190.48
2017-03-31 2016-12-31 -- $-29404.79
2016-11-14 2016-09-30 -- $-20119.07
2016-08-10 2016-06-30 -- $-23214.31
2016-05-13 2016-03-31 -- $230595.47
2015-11-13 2015-09-30 -- $0.00
2015-08-14 2015-06-30 -- $773810.25